Literature DB >> 27869049

Exclusion of overlapping symptoms in DSM-5 mixed features specifier: heuristic diagnostic and treatment implications.

Gin S Malhi1, Yulisha Byrow1, Tim Outhred1, Kristina Fritz1.   

Abstract

This article focuses on the controversial decision to exclude the overlapping symptoms of distractibility, irritability, and psychomotor agitation (DIP) with the introduction of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) mixed features specifier. In order to understand the placement of mixed states within the current classification system, we first review the evolution of mixed states. Then, using Kraepelin's original classification of mixed states, we compare and contrast his conceptualization with modern day definitions. The DSM-5 workgroup excluded DIP symptoms, arguing that they lack the ability to differentiate between manic and depressive states; however, accumulating evidence suggests that DIP symptoms may be core features of mixed states. We suggest a return to a Kraepelinian approach to classification-with mood, ideation, and activity as key axes-and reintegration of DIP symptoms as features that are expressed across presentations. An inclusive definition of mixed states is urgently needed to resolve confusion in clinical practice and to redirect future research efforts.

Entities:  

Keywords:  Agitated depression; DSM-5; bipolar disorder; depression; mixed features; mixed mania; mixed states

Mesh:

Substances:

Year:  2016        PMID: 27869049     DOI: 10.1017/S1092852916000614

Source DB:  PubMed          Journal:  CNS Spectr        ISSN: 1092-8529            Impact factor:   3.790


  1 in total

1.  Exploration of mood spectrum symptoms during a major depressive episode: The impact of contrapolarity-Results from a transdiagnostic cluster analysis on an Italian sample of unipolar and bipolar patients.

Authors:  Ludovico Mineo; Alessandro Rodolico; Giorgio Alfredo Spedicato; Andrea Aguglia; Simone Bolognesi; Carmen Concerto; Alessandro Cuomo; Arianna Goracci; Giuseppe Maina; Andrea Fagiolini; Mario Amore; Eugenio Aguglia
Journal:  Eur Psychiatry       Date:  2022-05-31       Impact factor: 7.156

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.